Literature DB >> 23953710

Real-time differential tracking of human neutrophil and eosinophil migration in vivo.

Joanna J Lukawska1, Lefteris Livieratos2, Barbara M Sawyer3, Tak Lee4, Michael O'Doherty2, Philip J Blower5, Martin Kofi6, James R Ballinger2, Christopher J Corrigan4, Gopinath Gnanasegaran6, Ehsan Sharif-Paghaleh3, Gregory E D Mullen7.   

Abstract

BACKGROUND: Hitherto, in vivo studies of human granulocyte migration have been based on indiscriminate labeling of total granulocyte populations. We hypothesized that the kinetics of isolated human neutrophil and eosinophil migration through major organs in vivo are fundamentally different, with the corollary that studying unseparated populations distorts measurement of both.
METHODS: Blood neutrophils and eosinophils were isolated on 2 separate occasions from human volunteers by using Current Good Manufacturing Practice CD16 CliniMACS isolation, labeled with technetium 99m-hexamethylpropyleneamine oxime, and then reinfused intravenously. The kinetics of cellular efflux were imaged over 4 hours.
RESULTS: Neutrophils and eosinophils were isolated to a mean purity of greater than 97% and greater than 95%, respectively. Activation of neutrophils measured as an increase in their CD11b mean fluorescence intensity in whole blood and after isolation and radiolabeling was 25.98 ± 7.59 and 51.82 ± 17.44, respectively, and was not significant (P = .052), but the mean fluorescence intensity of CD69 increased significantly on eosinophils. Analysis of the scintigraphic profile of lung efflux revealed exponential clearance of eosinophils, with a mean half-life of 4.16 ± 0.11 minutes. Neutrophil efflux was at a significantly slower half-life of 13.72 ± 4.14 minutes (P = .009). The migration of neutrophils and eosinophils was significantly different in the spleen at all time points (P = .014), in the liver at 15 minutes (P = .001), and in the bone marrow at 4 hours (P = .003).
CONCLUSIONS: The kinetics of migration of neutrophils and eosinophils through the lung, spleen, and bone marrow of human volunteers are significantly different. Study of mixed populations might be misleading.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  (99m)Tc-HMPAO; FITC; Fluorescein-5-isothiocyante; Granulocytes; HSA; Human serum albumin; MFI; Mean fluorescence intensity; PE; Phycoerythrin; ROI; Region of interest; TAC; Technetium 99m hexamethylpropyleneamine oxime; Time activity curve; bone marrow; eosinophils; kinetics; liver; lung; neutrophils; radiolabeled; spleen; technetium 99m–hexamethylpropyleneamine oxime

Mesh:

Substances:

Year:  2013        PMID: 23953710     DOI: 10.1016/j.jaci.2013.06.031

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  18 in total

Review 1.  Novel Therapies for Eosinophilic Disorders.

Authors:  Bruce S Bochner
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

Review 2.  Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging.

Authors:  Peter J Gawne; Francis Man; Philip J Blower; Rafael T M de Rosales
Journal:  Chem Rev       Date:  2022-05-12       Impact factor: 72.087

3.  Glucocorticoid-induced eosinopenia results from CXCR4-dependent bone marrow migration.

Authors:  So Gun Hong; Noriko Sato; Fanny Legrand; Manasi Gadkari; Michelle Makiya; Kindra Stokes; Katherine N Howe; Shiqin Judy Yu; Nathaniel Seth Linde; Randall R Clevenger; Timothy Hunt; Zonghui Hu; Peter L Choyke; Cynthia E Dunbar; Amy D Klion; Luis M Franco
Journal:  Blood       Date:  2020-12-03       Impact factor: 22.113

Review 4.  Options for imaging cellular therapeutics in vivo: a multi-stakeholder perspective.

Authors:  Brooke M Helfer; Vladimir Ponomarev; P Stephen Patrick; Philip J Blower; Alexandra Feitel; Gilbert O Fruhwirth; Shawna Jackman; Lucilia Pereira Mouriès; Margriet V D Z Park; Mangala Srinivas; Daniel J Stuckey; Mya S Thu; Tineke van den Hoorn; Carla A Herberts; William D Shingleton
Journal:  Cytotherapy       Date:  2021-04-06       Impact factor: 6.196

5.  [(18)F]FDG-6-P as a novel in vivo tool for imaging staphylococcal infections.

Authors:  Bethany Mills; Ramla O Awais; Jeni Luckett; Dave Turton; Paul Williams; Alan C Perkins; Philip J Hill
Journal:  EJNMMI Res       Date:  2015-03-19       Impact factor: 3.138

6.  Imaging Inflammation in Asthma: Real Time, Differential Tracking of Human Neutrophil and Eosinophil Migration in Allergen Challenged, Atopic Asthmatics in Vivo.

Authors:  Joanna J Lukawska; Lefteris Livieratos; Barbara M Sawyer; Tak Lee; Michael O'Doherty; Philip J Blower; Martin Kofi; James R Ballinger; Christopher J Corrigan; Gopinath Gnanasegaran; Ehsan Sharif-Paghaleh; Gregory E D Mullen
Journal:  EBioMedicine       Date:  2014-10-28       Impact factor: 8.143

7.  Destination Airway: Tracking Granulocytes in Asthma.

Authors:  Christopher E Brightling
Journal:  EBioMedicine       Date:  2014-11-07       Impact factor: 8.143

Review 8.  Mitochondria in the center of human eosinophil apoptosis and survival.

Authors:  Pinja Ilmarinen; Eeva Moilanen; Hannu Kankaanranta
Journal:  Int J Mol Sci       Date:  2014-03-05       Impact factor: 5.923

Review 9.  Regulation of spontaneous eosinophil apoptosis-a neglected area of importance.

Authors:  Pinja Ilmarinen; Eeva Moilanen; Hannu Kankaanranta
Journal:  J Cell Death       Date:  2014-02-10

10.  Opportunities and challenges for metal chemistry in molecular imaging: from gamma camera imaging to PET and multimodality imaging.

Authors:  Richard Southworth; Rafael Torres Martin de Rosales; Levente K Meszaros; Michelle T Ma; Gregory E D Mullen; Gilbert Fruhwirth; Jennifer D Young; Cinzia Imberti; Julia Bagunya-Torres; Erica Andreozzi; Philip J Blower
Journal:  Adv Inorg Chem       Date:  2015-11-16       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.